Assignee
PHARMALA BIOTECH INC
CA·2 granted patents·5 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
7 records- 0176US12042478B2(R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereofPHARMALA BIOTECH INC·Filed 2023·Granted Jul 23, 2024·0 cites·6 claims
- 0271US2024325338A1(r)-2-[(2h-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereofPHARMALA BIOTECH INC·Filed 2024·Application pending·0 cites
- 0367US12053452B2Compositions comprising non-racemic mixtures of (R)- and (S)-3,4- methylenedioxymethamphetamine or (R) and (S) n-methyl-1,3- benzodioxolylbutanamine and uses thereofPHARMALA BIOTECH INC·Filed 2023·Granted Aug 6, 2024·0 cites·13 claims
- 0467US2024335419A1Compositions comprising non-racemic mixtures of (r)- and (s)-3,4-methylenedioxymethamphetamine or (r) and (s) n-methyl-1,3-benzodioxolylbutanamine and uses thereofPHARMALA BIOTECH INC·Filed 2024·Application pending·0 cites
- 0561US2025170092A1(r)-2-[(2h-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereofPHARMALA BIOTECH INC·Filed 2025·Application pending·0 cites
- 0655US2024270710A1Processes for the preparation of the enantiomers of 3,4-methylenedioxymethamphetamine (mdma) and n-methyl-1,3-benzodioxolylbutanamine (mbdb)PHARMALA BIOTECH INC·Filed 2022·Application pending·0 cites
- 0754US2025170095A1Compositions comprising non-racemic mixtures of (r)- and (s)-3,4-methylenedioxymethamphetamine or (r) and (s) n-methyl-1,3-benzodioxolylbutanamine and uses thereofPHARMALA BIOTECH INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PHARMALA BIOTECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →